<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Brief Drug Interventions Delivered in General Medical Settings: A Systematic Review and Meta-Analysis of Cannabis Use Outcomes</title>
				<funder ref="#_nhdzsKY">
					<orgName type="full">National Institute on Drug Abuse</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institute on Drug Abuse or National Institutes of Health</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Lauren</forename><forename type="middle">M</forename><surname>Berny</surname></persName>
							<email>lberny@uoregon.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Counseling Psychology and Human Services</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Prevention Science Institute</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>M.S</roleName><forename type="first">Lindsey</forename><forename type="middle">M</forename><surname>Nichols</surname></persName>
							<email>lnichol2@uoregon.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Counseling Psychology and Human Services</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">The Warren Alpert Medical School</orgName>
								<orgName type="institution">Brown University</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Maria</forename><forename type="middle">L</forename><surname>Schweer-Collins</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Prevention Science Institute</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">University of Oregon</orgName>
								<orgName type="institution" key="instit2">HEDCO Institute for Evidence-Based Educational Practice</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Emily</forename><forename type="middle">E</forename><surname>Tanner-Smith</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Counseling Psychology and Human Services</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Prevention Science Institute</orgName>
								<orgName type="institution">University of Oregon</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">University of Oregon</orgName>
								<orgName type="institution" key="instit2">HEDCO Institute for Evidence-Based Educational Practice</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">University of Oregon Eugene</orgName>
								<address>
									<postCode>5251, 97403</postCode>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Brief Drug Interventions Delivered in General Medical Settings: A Systematic Review and Meta-Analysis of Cannabis Use Outcomes</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">01C86E4DA8997F54F9688504F0D441FA</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2025-10-22T06:22+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Brief interventions</term>
					<term>cannabis</term>
					<term>healthcare</term>
					<term>meta-analysis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>There is consistent evidence that brief interventions can be effective in preventing and reducing alcohol use, but support for their effects on illicit drug use is more limited. This meta-analysis builds upon prior research by testing whether brief drug interventions (BDIs) delivered in general medical settings reduce cannabis consumption and severity across post-intervention follow-up periods and explores potential heterogeneity in these intervention effects. Effect sizes from 17 randomized controlled trials were synthesized to compare short and long-term cannabis use outcomes between intervention and control groups. Mixed effects metaregression models were estimated to examine variability in effects across four intervention characteristics: booster session delivery, delivery setting, intervention target, and target population. Sensitivity tests were also conducted for both main effects and moderation analyses.</p><p>There was no evidence that BDIs yielded significant short-term reductions in cannabis use (OR = 1.20, 95% CI [0.90, 1.62]), frequency (g = 0.01, 95% CI [-0.07, 0.09]), or severity (g = 0.13, 95% CI [-0.07, 0.33]). Similarly, no evidence of long-term cannabis use (OR = 1.19, 95% CI [0.73, 1.86]) or frequency (g = 0.04, 95% CI [-0.05, 0.12]) were observed. Although the primary moderation analyses did not provide evidence of variation in effects, sensitivity tests revealed that BDIs delivered in emergency departments evidenced small but significant reductions in long-term frequency of cannabis use. Although these findings do not lend meaningful support for the overall effectiveness BDIs on cannabis consumption or severity when delivered in general medical settings, they do indeed provide secondary evidence that BDIs may perform more favorably when delivered in emergency departments. Thus, high-quality trials evaluating the effects of BDIs in emergency departments are needed. Further, given the importance of preventing adverse health outcomes and consequences of cannabis use, further research is clearly needed to improve and evaluate BDI outcomes as well as develop and test alternative prevention and intervention approaches to comprehensively address cannabis use.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Cannabis use in the United States has changed dramatically as legal recreational and medical availability of the drug has expanded. Cannabis use has increased in the general population, with past-month use among individuals ages 12 and older increasing by 38% between 2015 to 2019 <ref type="bibr" target="#b37">(Palamar et al., 2021)</ref>. Cannabis use disorder is also now prevalent: 69.7% of respondents ages 12 and older with an illicit substance use disorder met diagnostic criteria for cannabis use disorder in a recent national survey (Substance Abuse and Mental Health Services Administration [SAMHSA], 2023b). Adverse health effects of frequent cannabis use include but are not limited to cardiovascular and respiratory complications, poor sleep quality, decisionmaking deficits, and depression and anxiety symptom severity <ref type="bibr" target="#b11">(Fischer et al., 2022;</ref><ref type="bibr" target="#b24">Khalsa &amp; Baler, 2019;</ref><ref type="bibr" target="#b29">Leadbeater et al., 2019;</ref><ref type="bibr" target="#b30">Lovell et al., 2020)</ref>. Frequent cannabis use during adolescence, in particular, has been associated with poor health and psychosocial outcomes <ref type="bibr" target="#b15">(Hall &amp; Degenhardt, 2009)</ref>, with prospective studies linking regular cannabis use during adolescence with reduced educational attainment, increased risk of cannabis dependence, other illicit drug use, criminal activity, internalizing disorder symptoms, and suicidality <ref type="bibr" target="#b8">(Degenhardt et al., 2013;</ref><ref type="bibr" target="#b10">Fergusson et al., 2002;</ref><ref type="bibr" target="#b48">Silins et al., 2014)</ref>. Despite these consequences, treatment utilization rates for cannabis are low: only 7.8% of U.S. adults who met criteria for cannabis use disorder received cannabis-specific treatment in the past year <ref type="bibr" target="#b59">(Wu et al., 2017)</ref>, with lack of perceived need, affordability, and accessibility being among the most common reasons for not receiving treatment <ref type="bibr" target="#b23">(Kerridge et al., 2017)</ref>. Given the prevalence and potential consequences of cannabis use, interventions that address these barriers to treatment may be critical for identifying and preventing frequent cannabis use.</p><p>One such model is the brief intervention, defined here as a counseling intervention delivered within four or less sessions that aims to increase awareness of substance use consequences and thereby reduce consumption. As a whole, brief interventions are heterogenous in their approach; other than their brevity, these interventions can vary in structure, core components, and delivery methods. Some brief interventions simultaneously target co-occurring alcohol and drug use, whereas others may focus solely on alcohol or participants' drug of choice (e.g., cannabis); such flexibility allows brief interventions to be administered to broader populations or tailored to specific groups such as adolescents or university students <ref type="bibr" target="#b32">(Mattoo et al., 2018;</ref><ref type="bibr" target="#b42">Roche &amp; Freeman, 2004)</ref>. Although brief interventions can be delivered in a variety of settings, embedding them into services in general medical settings-such as emergency departments, community health centers, primary care clinics, and student health centerspresents a potential opportunity to make substance use prevention and referral to treatment more accessible. Further, because frequent substance use and substance use disorders are often overrepresented in samples of individuals who receive clinical services in emergency departments and primary care clinics <ref type="bibr" target="#b5">(Cherpitel &amp; Ye, 2008;</ref><ref type="bibr" target="#b40">Pilowsky &amp; Wu, 2012)</ref>, these settings also facilitate a unique opportunity to address substance use with a high volume of atrisk individuals who may not be seeking substance use treatment. Nonetheless, although clinicians in general medical settings are well-positioned to screen for and discuss substance use with their patients, they often have minimal time and resources to provide services beyond treating presenting conditions. Thus, brief interventions are often appealing in these settings given their short duration, limited need for implementation training, and possible cost-efficiency <ref type="bibr" target="#b0">(Barbosa et al., 2017)</ref>. Taken together, the potential reach, adaptability, and feasibility of brief interventions delivered in general medical settings make them a pragmatic approach to opportunistically address cannabis use. As such, it is crucial to assess the evidence of their efficacy.</p><p>Although reviews of brief alcohol interventions have shown beneficial yet modest reductions in drinking <ref type="bibr" target="#b22">(Kaner et al., 2018)</ref>, support for brief drug interventions (BDIs) is more limited <ref type="bibr" target="#b45">(Saitz, 2014)</ref>. Recent meta-analyses of BDIs have revealed mixed results, showing evidence of beneficial reductions in drug use as well as null results <ref type="bibr" target="#b16">(Halladay et al., 2019;</ref><ref type="bibr" target="#b21">Imtiaz et al., 2020;</ref><ref type="bibr" target="#b44">Sahker et al., 2022;</ref><ref type="bibr" target="#b52">Tanner-Smith et al., 2022)</ref>. It is possible that BDI effects may vary across different study and intervention characteristics and thus contribute to these mixed results. One important such characteristic is the setting in which the intervention is delivered. For example, a recent meta-analysis found no evidence that brief interventions delivered in outpatient medical facilities reduced frequency of drug use, but effects significantly varied across delivery settings, with subgroup analyses revealing that interventions delivered in emergency departments yielded small positive reductions in drug use frequency <ref type="bibr" target="#b44">(Sahker et al., 2022)</ref>. It is also possible that these BDIs may have greater beneficial effects in certain populations and/or when specifically targeting specific substances. For instance, another recent meta-analysis found that cannabis-targeted BDIs for adolescent and young adults were associated with small reductions in short-term cannabis use disorder symptoms and higher odds of short-term abstinence <ref type="bibr" target="#b16">(Halladay et al., 2019)</ref>. However, the same meta-analysis found no evidence of reductions in cannabis use frequency or consequences of cannabis use, suggesting that results may vary across outcomes domains or measures. Differences in the structures and components of Given the potential consequences of cannabis use and low receipt of treatment for cannabis related problems, the primary aim of this meta-analysis is to evaluate whether BDIs delivered opportunistically in general medical settings result in beneficial reductions in the consumption and severity of cannabis use. As a secondary aim, this meta-analysis examines the variability in effects across patient populations, settings, intervention targets, and booster session delivery. The current meta-analysis builds upon and makes important contributions to the existing literature. Two recent studies have used meta-analytic methods to synthesize the effects of brief interventions delivered specifically in healthcare settings on cannabis outcomes. First is a synthesis of findings from six studies examining the effects of BDIs delivered in healthcare settings with patients who reported recent cannabis use, which reported no evidence of effects on frequency of cannabis use nor severity or cannabis use <ref type="bibr" target="#b21">(Imtiaz et al., 2020)</ref>. Second was a review synthesizing findings from 111 studies of brief interventions delivered in general medical settings, which reported a subgroup analysis among 13 studies indicating small beneficial effects of BDIs on cannabis use that attenuated to non-significance after adjusting for multiple comparisons <ref type="bibr" target="#b52">(Tanner-Smith et al., 2022)</ref>. Both of these reviews therefore suggest that BDIs delivered in general medical settings may have modest to minimal effects on cannabis consumption outcomes. However, neither of these reviews conducted more in-depth analyses to examine whether BDI effects on cannabis use might vary across study or intervention characteristics. Given the likely variability in the ways that BDIs are implemented in different general medical settings, it is essential to explore such potential heterogeneity use before concluding that that they have consistently small or null effects on cannabis use outcomes.</p><p>Therefore, the present meta-analysis conducts new analyses using data from Tanner-Smith et al.</p><p>(2022), which expand the current evidence base by examining multiple cannabis use outcomes across different post-intervention follow-up periods as well as estimating meta-regression models to further explore heterogeneity in BDI effects.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p>Methods and findings are reported following the PRISMA 2020 reporting guidelines for systematic reviews with meta-analysis <ref type="bibr" target="#b36">(Page et al., 2021)</ref>. The protocols for both the parent systematic review and meta-analysis as well as this secondary analysis were pre-registered and posted on Open Science Framework. There were two post hoc deviations from the analysis protocol that were exploratory in nature, as described in greater detail below: (1) the addition of sensitivity tests to assess the impact of effect size selection based on follow-up time and intervention modality; and (2) applying effect size selection sensitivity tests to moderation analyses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Eligibility Criteria and Search Strategy</head><p>This meta-analysis analyzes a subset of studies from a larger parent meta-analysis evaluating the effectiveness of brief substance use interventions delivered in general medical settings <ref type="bibr" target="#b52">(Tanner-Smith et al., 2022)</ref>. The parent meta-analysis included brief interventions targeting alcohol use, other drug use, or mixed substance use (i.e., both alcohol and other drug use). To be eligible for inclusion in the parent meta-analysis, studies had to evaluate substance use brief interventions delivered in four or fewer sessions to patients recruited from general, nonspecialized medical service settings. Eligible studies were required to use a randomized controlled trial design to compare the brief interventions with less active comparison conditions (e.g. no treatment, sham, and treatment as usual) and report at least one post-intervention measure of substance use or substance use-related consequences. To be eligible for inclusion in the present analytic sample, studies were required to evaluate the effects of a BDI-defined here as explicitly targeting drug use either singularly or in conjunction with alcohol use-and report post-intervention measures of cannabis consumption or severity. As such, studies evaluating interventions that only targeted alcohol but measured cannabis consumption or severity as secondary outcomes were ineligible <ref type="bibr" target="#b2">(Bernstein et al., 2010;</ref><ref type="bibr" target="#b4">Cancilliere et al., 2018)</ref>.</p><p>The parent meta-analysis used a comprehensive search strategy to identify relevant Reference lists of all screened and eligible studies and those in prior narrative reviews and metaanalyses were reviewed. Hand searches were also performed of the 1990 to 2020 table of contents in Addiction, Addictive Behaviors, Campbell Systematic Reviews, and Journal of Studies on Alcohol and Drugs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Selection and Data Extraction</head><p>A rigorous three-stage study selection and data extraction process was conducted by trained research assistants as part of the parent meta-analysis' protocol. First, two reviewers independently screened titles and abstracts to eliminate studies that did not meet the search criteria. Any of the studies considered potentially relevant for inclusion by at least one reviewer proceeded to the second stage, during which two reviewers independently reviewed the full texts to determine final eligibility. At the third stage, two reviewers independently coded and extracted data for all eligible studies. Any disagreements during the second and third stages were resolved by the Principal Investigator. This data extraction process followed a pre-registered, standardized coding protocol (see <ref type="bibr" target="#b52">Tanner-Smith et al., 2022</ref> for additional details). The Cochrane Collaboration's risk of bias tool for randomized controlled trials was used to assess risk of bias in the included studies <ref type="bibr" target="#b19">(Higgins et al., 2011)</ref>.</p><p>In the current meta-analysis, the first author (LMB) reviewed the studies that met its inclusion criteria to determine whether BIs were designed to target cannabis, which was a moderator of interest. After that independent review, the second author (LMN) reviewed the coding for consensus.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcomes</head><p>To comprehensively examine BDI effects on cannabis use, we examined three outcomes:</p><p>(1) frequency of use (defined as number of days cannabis was used or quantity of cannabis used; continuous outcome); (2) general use (any cannabis use; binary outcome); and (3) severity of use (defined as continuous ASSIST scores; WHO ASSIST Working Group, 2002). These outcomes were assessed separately for short-term and long-term follow-up periods, defined as 0-5 months and 6-12 months post-intervention, respectively.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Moderators</head><p>The present meta-analysis examined the following potential effect size moderators: (1) delivery of a booster session (yes vs. no); (2) primary setting (emergency department, community health centers, student health centers, hospital-based primary care, or multiple settings); (3) BDI target (cannabis-targeted BDIs vs. BDIs targeting other drugs or mixed substance use); and (4) sample population (adolescents only, adolescents and young adults, mixed/adults only, and university students).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect Size Metrics</head><p>Continuous outcomes of interest were measured using the small-sample corrected standardized mean difference <ref type="bibr">(Hedges' g;</ref><ref type="bibr" target="#b18">Hedges, 1981)</ref>, with positive values indicating beneficial effects (i.e., greater reductions in cannabis use or severity compared to control conditions). For the binary outcome of general cannabis use, we used log odds ratio effect sizes, with higher values indicating greater odds of not using cannabis compared to the control conditions. Log odds were transformed to odds ratios in narrative interpretations of those outcomes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect Size Independence</head><p>To ensure each meta-analysis pooled a set of statistically independent effect sizes, only one effect size from each study was included for each analysis model. If studies reported multiple measures of cannabis use frequency, the following hierarchy was used for effect size selection, in order of preference: (1) frequency of use measured in days (e.g., days of cannabis use over the past month); (2) frequency of use measured in times cannabis was used over a week or longer time period (e.g., number of times cannabis was used over the past month); and (3) quantity of cannabis consumed (e.g., number of cannabis joints smoked over the past month). If studies reported general cannabis use for multiple recall periods, the effect size closest to the modal recall period was selected.</p><p>For studies that measured the same outcome at multiple timepoints within the short-term and long-term follow-up periods, the effect size closest to the modal timepoint was selected. In the event a modal timepoint was not present, preference was given to the earlier timepoint.</p><p>Additionally, some studies included multiple intervention groups. For multi-arm studies that tested different intervention enhancements, the contrast between the most minimal control group and most intensive intervention was selected. When multi-arm studies evaluated interventions delivered both in person and electronically, effect sizes for in-person interventions were retained as that was the most common modality in the analytic sample.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analytic Strategy</head><p>First, we estimated random-effects models with the restricted maximum likelihood estimator for τ 2 to synthesize effect sizes of short-term and long-term results, defined as being measured at 0-5 months and 6-12 months post-intervention, respectively. Because only one study measured severity at a long-term follow-up, only short-term severity results were synthesized.</p><p>Next, mixed effects meta-regression models were estimated with the Knapp and Hartung adjustment to examine the moderators of interest <ref type="bibr" target="#b25">(Knapp &amp; Hartung, 2003)</ref>. For subsequent subgroup analyses, the between studies variance (τ 2 ) was computed within subgroups; then, each estimate of τ 2 was pooled and applied to all the subgroups. Forest plots were used to visually display these results.</p><p>Sensitivity tests were conducted to assess the impact of effect size selection based on timepoint, intervention intensity, and BDI modality. For studies that reported multiple effect sizes within a follow-up period, we assessed whether choosing an alternative follow-up timepoint, less intensive intervention contrast, or electronic modality, impacted the findings. These sensitivity tests were only conducted for cannabis frequency and use outcomes because none of the severity outcome analyses were affected by these selection factors. Additionally, timepoint sensitivity tests were limited to outcomes that were reported at multiple timepoints in the included studies. Thus, because the effect size selection process described above resulted in all selected short-term effect sizes being measured at three months post-intervention, timepoint sensitivity tests were not conducted for short-term outcomes. Last, for outcomes with ten or more effect sizes included in the synthesis, funnel plots, regression tests for funnel plot asymmetry, and trim and fill analysis were used to assess for potential publication bias <ref type="bibr" target="#b9">(Egger et al., 1997;</ref><ref type="bibr" target="#b43">Rothstein et al., 2005)</ref>. All analyses were conducted in R using the metafor package <ref type="bibr">(version 4.4;</ref><ref type="bibr" target="#b53">Viechtbauer, 2010)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The PRISMA flow chart is displayed in Figure <ref type="figure">1</ref>. The parent study included effect sizes from 111 studies in the overall meta-analysis. Seventy-three of those studies were excluded from the present analysis due to an ineligible intervention (i.e., alcohol focused interventions). Among the remaining 38 BDIs, 21 studies were excluded due to ineligible outcomes (i.e., no cannabis outcomes reported). The remaining 17 studies were eligible for inclusion in the current metaanalysis, comprising data collected from 23 unique study samples and reported in 18 reports. As shown in Table <ref type="table" target="#tab_0">1</ref>, most studies took place in the United States or Canada (82%). Using the Cochrane Collaboration's risk of bias tool for randomized controlled trials <ref type="bibr" target="#b19">(Higgins et al., 2011)</ref>, the majority of studies were rated as having an unclear risk of bias (82%), with allocation concealment, blinding of outcome assessors, and selective reporting being the domains with the greatest risk for bias (study-level risk of bias ratings are reported in Supplemental Material 1).</p><p>All studies included a CONSORT diagram. The most common delivery settings were community health centers (41%) and emergency departments (29%). Most interventions targeted mixed age groups or adults only (41%) and adolescents only (29%). Thirty-five percent of the BDIs included a booster, and only six studies (35%) specifically targeted cannabis use vs. other drugs/multiple drugs. Study-level characteristics are reported in Table <ref type="table">2</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Main Effects</head><p>Standardized effect sizes and heterogeneity statistics are reported in Table <ref type="table">3</ref> for all estimable time periods and outcomes. Long-term severity effects could not be synthesized because only one eligible study measured cannabis use severity during that follow-up period.</p><p>Forest plots of these models are also displayed in Supplemental Material 2.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cannabis Use Frequency</head><p>Relative to practice as usual controls, there was no evidence of significant reductions in short-term (k = 12, g = 0.01, 95% CI [-0.07, 0.09], p = .802) or long-term (k = 11, g = 0.04, 95% CI [-0.05, 0.12], p = .413) frequency of cannabis use in participants assigned to BDIs. In other words, there was less than a 0.05 standard deviation difference in reported frequency of cannabis use between the BDI and control groups during both time periods. Indeed, although 13 of the 23 total cannabis frequency effect sizes were positive, none were statistically significant. There was no evidence of between-study heterogeneity in short-term (τ 2 = 0.00, I 2 = 0.00%) or long-term (τ 2 = 0.03, I 2 = 5.15%) frequency.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cannabis Use</head><p>No evidence of significant reductions in short-term (k = 3, logOR = 0.19, 95% CI [-0.11, 0.48], p = .217) or long-term (k = 4, logOR = 0.18, 95% CI [-0.32, 0.67], p = .488) cannabis use were observed in participants assigned to BDIs relative to practice as usual controls. Interpreted another way, the odds of not using cannabis were approximately 20% higher for participants assigned to BDIs versus those assigned to the control groups, but these differences were not statistically significant. Despite four out of seven total cannabis use effect sizes showing positive effects, only one was statistically significant. Although there was no evidence of between-study heterogeneity in short-term cannabis use (τ 2 = 0.00, I 2 = 0.00%), there was evidence of heterogeneity between studies measuring long-term use (Q(3) = 8.61, τ 2 = 0.16%, p = .035), with 63.85% of the observed heterogeneity reflecting variance in true effects rather than sampling error. Thus, considerable variation in the long-term odds of not using cannabis could be expected in future BDI trials (95% PI = [0.47, 3.04]).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cannabis Use Severity</head><p>Synthesis of seven independent effect sizes (81% positive) from four studies showed no evidence of significant reductions in short-term cannabis use severity for participants assigned to BDIs relative to practice as usual controls (g = 0.13, 95% CI [-0.07, 0.33], p = .199). In other words, there was a 0.13 standard deviation difference in reported severity between the BDI and control groups. There was evidence of minimal heterogeneity between these studies (τ 2 = 0.04, Q(6) = 13.39, p = .037), with 63.7% of the observed heterogeneity reflecting variance in true effects rather than sampling error. Thus, considerable variation in short-term effects on cannabis severity could be expected in future BDI trials (95% PI = [-0.31, 0.57]).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Moderation Analysis</head><p>Subgroup effect sizes and 95% confidence intervals for the moderation analyses are reported in Table <ref type="table">4</ref>. Although short-term use outcomes are reported for completeness, the results should be interpreted with caution due to large standard errors and limited degrees of freedom.</p><p>Overall, there was no evidence that effects of BDIs were moderated by booster session status (F = 1.12, p = .367), setting (F = 3.02, p = .094), intervention target (F = 3.05, p = .745), nor population (F = 1.40, p = .326). Moreover, none of the subgroups were associated with significant changes in cannabis outcomes during either follow-up period.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sensitivity Tests</head><p>The main effect findings from the sensitivity tests were consistent with those of the primary analysis reported above (full results are reported in Supplemental Material 3). The sensitivity tests for the moderator analysis findings were also generally consistent with the primary findings reported above, with one notable exception. BDIs implemented in emergency departments evidenced small but significant reductions in cannabis use frequency when selecting alternative effect sizes based on follow-up timepoint (g = 0.15 [0.00, 0.30], p = .049), intervention intensity (g = 0.17 [0.03, 0.31], p = .024), and modality (g = 0.16 [0.01, 0.31], p = .042). As shown by the forest plot in Figure <ref type="figure" target="#fig_2">2</ref>, these selection choices resulted in a higher effect size for this subgroup than obtained from the primary analytic sample (g = 0.13 [-0.00, 0.27], p = .054). Full moderation results for the sensitivity tests are reported in Supplemental Material 4.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>This meta-analysis had two primary aims: to (1) evaluate the effects of BDIs delivered in general medical settings on cannabis outcomes; and (2) assess whether those effects varied by booster session status, intervention target, setting, and population. Overall, we found no evidence of consistently beneficial or harmful effects of BDIs on frequency of cannabis use, general cannabis use, or severity of use at both short-term and long-term follow-up periods. There was also no evidence these effects were moderated by booster session status, intervention target, setting, or population. Overall, these findings were generally consistent across a variety of sensitivity tests but may be admittedly conservative; nonetheless, the results do not lend evidence that implementing BDIs in general healthcare would lead to consistent reductions in medical patients' cannabis consumption or severity.</p><p>Findings from the sensitivity analyses, however, suggest these results may be conservative, and there is a subgroup for whom BDIs may lead to beneficial long-term effects on cannabis outcomes. In each of the three sensitivity tests, BDIs delivered in emergency departments were associated with significant reductions in cannabis use frequency, providing secondary evidence that BDIs may perform more favorably when delivered in emergency departments. This is consistent with a recent review that found that only BDIs delivered in emergency departments had significant reductions in drug use frequency <ref type="bibr" target="#b44">(Sahker et al., 2022)</ref> and suggests that BDIs may be better suited for implementation in that specific setting. These more favorable results may stem from the high prevalence of emergency department visits attributed to substance use, with cannabis being the second most common illicit drug involved in admissions <ref type="bibr">(SAMHSA, 2023a)</ref>. It is possible that individuals seeking treatment at an emergency department may have more severe presentations and thus benefit more from a single BDI.</p><p>Additionally, if the emergency department visit stemmed from cannabis or other drug-related consequences (e.g., cannabinoid hyperemesis syndrome, vehicle accidents), participants may have greater motivation to make behavioral changes and thus be better candidates for BDIs <ref type="bibr" target="#b17">(Hawk &amp; D'Onofrio, 2018)</ref>.</p><p>Nevertheless, the null results for the main effects are consistent with other meta-analyses evaluating BDIs delivered in healthcare settings <ref type="bibr" target="#b21">(Imtiaz et al., 2020;</ref><ref type="bibr" target="#b52">Tanner-Smith et al., 2022)</ref>.</p><p>Similarly, other trials have reported no evidence of reductions in cannabis outcomes after delivering brief interventions in healthcare settings <ref type="bibr" target="#b2">(Bernstein et al., 2010;</ref><ref type="bibr" target="#b4">Cancilliere et al., 2018;</ref><ref type="bibr" target="#b41">Poblete et al., 2017)</ref>. Brief interventions remain a compelling approach to reducing substance use and related consequences given their brevity and low cost, consistent evidence of beneficial effects on reducing alcohol use, and importance as a first step along the continuum of care <ref type="bibr" target="#b16">(Halladay et al., 2019)</ref>. BDIs, in particular, may be integral in linking individuals to further substance use treatment as prior studies have found that participants who received BDIs were significantly more likely to attend substance use treatment during the follow-up periods than participants in the comparison groups <ref type="bibr" target="#b27">(Krupski et al., 2010;</ref><ref type="bibr" target="#b51">Tait et al., 2004)</ref>. However, these null findings clearly warrant consideration of how BDIs delivered in general medical settings can be improved upon to address cannabis consumption and severity. Another possibility is that BDIs targeting cannabis use are differentially effective for patients with different identities or presenting characteristics. For example, Schweer-Collins and colleagues (2023) explored whether BDIs varied according to patient sex, age, housing status, relationships status, education level, and baseline severity of drug or alcohol use using individual patient data; however, no evidence of variability was found for any cannabis or drug-use related outcomes. Similar to the current study, there were few studies exploring the outcomes of drug-specific BDIs (k = 2-5) and thus future studies should continue to explore the populations for whom and settings under which BDIs targeting cannabis use are more or less effective.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p>Although this meta-analysis fills important gaps in the knowledge base around BDIs, its findings should be viewed in light of its limitations. First, given the small number of studies evaluating the effects of BDIs on cannabis use, the power to assess heterogeneity was inherently limited. Second, none of the included studies reported outcomes collected after 12-months postintervention. Therefore, these findings cannot be generalized to longer follow-up periods. Third, both biomarkers and self-report instruments were used to measure cannabis use in the included studies. The validity of self-report instruments in BDI trials is a concern due to social desirability bias and potential underreporting of illicit substance use <ref type="bibr" target="#b45">(Saitz, 2014)</ref>, which may contribute to differences in intervention effects across studies. Fourth, all synthesized studies included in this meta-analysis were rated as having unclear or high overall risk of bias. Thus, it is unknown how these findings would change if they were conducted with a lower risk of bias.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Future Considerations</head><p>As cannabis use continues to evolve in the wake of medical and recreational legalization, it may be beneficial for BDIs targeting people who use cannabis to include more harm reduction strategies. This could include content about using lower-potency cannabis products and adopting alternative routes of use over smoking cannabis to reduce pulmonary health risks <ref type="bibr" target="#b11">(Fischer et al., 2022)</ref>. Delaying the onset of cannabis use to adulthood has also been identified as a harm reduction strategy as prior research suggests that doing so can reduce the risk of adverse health outcomes <ref type="bibr" target="#b11">(Fischer et al., 2022)</ref>, but only two of the trials included in this meta-analysis tested the effects of BDIs targeting youth who reported never using cannabis <ref type="bibr" target="#b26">(Knight et al., 2019;</ref><ref type="bibr" target="#b56">Walton et al., 2014)</ref>. As such, youth-focused preventive BDIs delivered in general medical settings warrant further exploration, with particular attention to their developmental appropriateness and timing in order to ensure maximal impact <ref type="bibr" target="#b35">(Nation et al., 2003)</ref>.</p><p>In addition, further research is needed to expand and improve upon the current body of evidence. Given the sensitivity results showing some evidence of greater benefit of BDIs in ED settings, high-quality trials evaluating the effects of BDIs in emergency departments are needed.</p><p>Trials should also be conducted in urgent care centers and free-standing emergency departments to evaluate whether effects may vary across different models of emergency medical treatment. Moreover, it is possible that BDIs implemented in other settings may have greater beneficial effects on cannabis outcomes. For example, a meta-analysis that synthesized the effects of cannabis-targeted brief interventions delivered in school, healthcare, truancy centers, and general community settings found that adolescents and young adults assigned to the intervention groups had higher rates of abstinence (i.e., no use of cannabis) and lower cannabis use disorder symptoms at 1-3 months post-intervention versus those assigned to control groups <ref type="bibr" target="#b16">(Halladay et al., 2019)</ref>. As such, researchers should continue to synthesize the evidence of BDI trials in other settings to further assess this. Given recent reviews highlighting the importance of the duration and components (e.g., motivational interviewing, personalized feedback) of cannabis-targeted brief interventions <ref type="bibr" target="#b12">(Gex et al., 2024;</ref><ref type="bibr" target="#b39">Parmar &amp; Sarkar, 2017)</ref>, future meta-analyses should include these characteristics as candidate moderators to investigate if and to what extent the cannabis use outcomes may vary across them. Finally, more effort should be placed into developing and testing alternative prevention and intervention approaches to comprehensively address cannabis use as well as increasing access to and strengthening referral systems for substance use treatment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protocol Registration</head><p>Protocol for the parent systematic review and meta-analysis was pre-registered in PROSPERO (CRD42018086832). The analytic plan for this review was pre-registered in OSF: https://osf.io/c82vg     </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>interventions are also important to consider when evaluating BDI effects. One such characteristic is whether interventions include booster sessions to help sustain intervention effects. Although booster sessions are often employed with brief interventions, evidence about the impact of boosters is mixed. For instance, when evaluating the effects of brief interventions delivered in general medical settings, Tanner-Smith et al. (2022) found that delivery of a booster in brief alcohol interventions was associated with significant reductions in alcohol use, whereas BDIs delivered without a booster had larger beneficial reductions in mixed substance use (i.e., alcohol and other drug use) compared to BDIs with a booster. Thus, given the variation in BDI effects, attempts to synthesize the literature on BDIs should attend carefully to such potential heterogeneity in effects.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>published and unpublished studies, which yielded the studies considered for inclusion in the present meta-analysis. The following databases (hosts) were searched from 1990 through March 31, 2020: PubMed; Nursing/Academic Edition (EBSCO); ERIC, Applied Social Sciences Index and Abstracts, Dissertations and Theses Global, Social Services Abstract (ProQuest); PsycINFO (PsycNET); Cochrane Central Register of Controlled Trials; World Health Organization (WHO) International Clinical Trials Registry; and National Institutes of Health (NIH) RePORTER.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 Forest</head><label>2</label><figDesc>Figure 2Forest Plot of the Effects of Brief Drug Interventions of Long-Term Cannabis Use Frequency</figDesc><graphic coords="36,72.00,119.97,576.00,306.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 Forest</head><label>3</label><figDesc>Figure 3Forest Plot of the Effects of Brief Drug Interventions of Short-Term Cannabis Use</figDesc><graphic coords="37,72.00,119.97,576.00,216.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 Forest</head><label>4</label><figDesc>Figure 4Forest Plot of the Effects of Brief Drug Interventions of Long-Term Cannabis Use</figDesc><graphic coords="38,72.00,119.97,576.00,216.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 5 Forest</head><label>5</label><figDesc>Figure 5Forest Plot of the Effects of Brief Drug Interventions of Short-Term Cannabis Use Severity</figDesc><graphic coords="39,72.00,119.97,576.00,270.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="32,68.00,110.00,468.00,473.50" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="35,72.00,142.86,576.00,324.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Aggregate Characteristics of Included Studies (k = 17)   </figDesc><table><row><cell>Characteristic</cell><cell>k (%)</cell><cell>Characteristic</cell><cell>k (%)</cell></row><row><cell>Country</cell><cell></cell><cell>Setting</cell><cell></cell></row><row><cell>United States</cell><cell>14 (82.4%)</cell><cell>Community health center</cell><cell>7 (41.2%)</cell></row><row><cell>Africa</cell><cell>1 (5.9%)</cell><cell>Emergency department</cell><cell>5 (29.4%)</cell></row><row><cell>Europe</cell><cell>1 (5.9%)</cell><cell>Multiple</cell><cell>2 (11.8%)</cell></row><row><cell>Multiple</cell><cell>1 (5.9%)</cell><cell>University health center</cell><cell>2 (12.8%)</cell></row><row><cell></cell><cell></cell><cell>Hospital-based primary care</cell><cell>1 (5.9%)</cell></row><row><cell>Risk of Bias</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Random sequence generation</cell><cell></cell><cell>Population</cell><cell></cell></row><row><cell>Low</cell><cell>11 (64.7%)</cell><cell>Mixed ages and adults only</cell><cell>7 (41.2%)</cell></row><row><cell>Unclear</cell><cell>6 (35.3%)</cell><cell>Adolescents only</cell><cell>5 (29.4%)</cell></row><row><cell>Allocation concealment</cell><cell></cell><cell>Adolescents and young adults</cell><cell>3 (17.6%)</cell></row><row><cell>Low</cell><cell>8 (47.1%)</cell><cell>University students</cell><cell>2 (11.8%)</cell></row><row><cell>Unclear</cell><cell>9 (52.9%)</cell><cell></cell><cell></cell></row><row><cell>Blinding of outcome assessors</cell><cell></cell><cell>Booster Session</cell><cell></cell></row><row><cell>Low</cell><cell>1 (5.9%)</cell><cell>No</cell><cell>11 (64.7%)</cell></row><row><cell>High</cell><cell>1 (5.9%)</cell><cell>Yes</cell><cell>6 (35.3%)</cell></row><row><cell>Unclear</cell><cell>15 (88.2%)</cell><cell></cell><cell></cell></row><row><cell>Selective reporting</cell><cell></cell><cell>Intervention Target</cell><cell></cell></row><row><cell>Low</cell><cell>3 (17.6%)</cell><cell>Other drug/mixed substances</cell><cell>11 (64.7%)</cell></row><row><cell>High</cell><cell>1 (5.9%)</cell><cell>Cannabis</cell><cell>6 (35.3%)</cell></row><row><cell>Unclear</cell><cell>13 (76.5%)</cell><cell></cell><cell></cell></row><row><cell>Incomplete outcome data</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Low</cell><cell>10 (58.8%)</cell><cell></cell><cell></cell></row><row><cell>High</cell><cell>1 (5.9%)</cell><cell></cell><cell></cell></row><row><cell>Unclear</cell><cell>6 (35.3%)</cell><cell></cell><cell></cell></row><row><cell>Other Bias</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Low</cell><cell>13 (76.5%)</cell><cell></cell><cell></cell></row><row><cell>Unclear</cell><cell>4 (23.5%)</cell><cell></cell><cell></cell></row><row><cell>Overall risk of bias</cell><cell></cell><cell></cell><cell></cell></row><row><cell>High</cell><cell>3 (17.6%)</cell><cell></cell><cell></cell></row><row><cell>Unclear</cell><cell>14 (82.4%)</cell><cell></cell><cell></cell></row><row><cell>Consort Diagram</cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell>0 (0.0%)</cell><cell></cell><cell></cell></row><row><cell>Yes</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="funding">
<div><head>Funding</head><p>Data collection for this sample was originally supported by the <rs type="funder">National Institute on Drug Abuse</rs> [<rs type="grantNumber">R01DA029785</rs>]. The content is solely the responsibility of the authors and does not necessarily represent the official position or policy of the <rs type="funder">National Institute on Drug Abuse or National Institutes of Health</rs>.</p></div>
<div><head>Disclosure of Potential Conflicts of Interest</head><p>None of the other authors report any potential conflicts of interest.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_nhdzsKY">
					<idno type="grant-number">R01DA029785</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethical Approval</head><p>The University of Oregon Institutional Review Board (IRB) reviewed the protocol for this review and determined that the study activities did not meet the definition of research with human subjects according to Title 45 CFR 46.102 (d-f) and thus did not require IRB approval.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Informed Consent</head><p>This meta-analysis did not involve the collection of data from human subjects. As such, no informed consent was required.      </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplemental Material S3: Main Effect Results From Sensitivity Tests</head><p>There was no evidence of funnel plot asymmetry in the short-term (z = 1.08, p = .278) long-term (z = 1.12, p = .261) frequency outcomes, and trim and fill analyses did not yield different findings.</p><p>Despite between-study heterogeneity in long-term cannabis use frequency not being statistically significant, the substantial increase in I 2 values for the timepoint and intervention intensity sensitivity tests reflect greater variability those studies. Note. Subscripts denote the number of independent effect sizes included for each outcome; frequency and severity effect sizes are Hedges' g and use effect sizes are logORs; ES = effect size; CI = 95% confidence intervals; PI = 95% prediction intervals.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplemental Material S4: Moderation Results From Sensitivity Tests</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The costeffectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States</title>
		<author>
			<persName><forename type="first">C</forename><surname>Barbosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dowd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Landwehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aldridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bray</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.13658</idno>
		<ptr target="https://doi.org/10.1111/add.13658" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">S2</biblScope>
			<biblScope unit="page" from="73" to="81" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dorfman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bliss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bernstein</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1553-2712.2009.00490.x</idno>
		<ptr target="https://doi.org/10.1111/j.1553-2712.2009.00490.x" />
	</analytic>
	<monogr>
		<title level="j">Academic Emergency Medicine</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1174" to="1185" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A brief motivational interview in a pediatric emergency department, plus 10-day telephone follow-up, increases attempts to quit drinking among youth and young adults who screen positive for problematic drinking</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Edward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dorfman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bliss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bernstein</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1553-2712.2010.00818.x</idno>
		<ptr target="https://doi.org/10.1111/j.1553-2712.2010.00818.x" />
	</analytic>
	<monogr>
		<title level="j">Academic Emergency Medicine</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="890" to="902" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A randomized controlled trial of brief interventions to reduce drug use among adults in a low-income urban emergency department: The HealthiER You study</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Blow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Walton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S B</forename><surname>Bohnert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Ignacio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chermack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ilgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Barry</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.13773</idno>
		<ptr target="https://doi.org/10.1111/add.13773" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1395" to="1405" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Brief alcohol interventions for youth in the emergency department: Exploring proximal and distal outcomes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Cancilliere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spirito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Monti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Barnett</surname></persName>
		</author>
		<idno type="DOI">10.1080/1067828X.2018.1529645</idno>
		<ptr target="https://doi.org/10.1080/1067828X.2018.1529645" />
	</analytic>
	<monogr>
		<title level="j">Journal of Child &amp; Adolescent Substance Abuse</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="311" to="321" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Drug use and problem drinking associated with primary care and emergency room utilization in the us general population: Data from the</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Cherpitel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ye</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2008.03.033</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2008.03.033" />
	</analytic>
	<monogr>
		<title level="j">National Alcohol Survey. Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="226" to="230" />
			<date type="published" when="2005">2008. 2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Brief motivational interviewing for teens at risk of substance use consequences: A randomized pilot study in a primary care clinic</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>*d'amico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N V</forename><surname>Miles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Meredith</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsat.2007.08.008</idno>
		<ptr target="https://doi.org/10.1016/j.jsat.2007.08.008" />
	</analytic>
	<monogr>
		<title level="j">Journal of Substance Abuse Treatment</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="61" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Brief motivational interviewing intervention to reduce alcohol and marijuana use for atrisk adolescents in primary care</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>*d'amico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Parast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Shadel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Meredith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Seelam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Stein</surname></persName>
		</author>
		<idno type="DOI">10.1037/ccp0000332</idno>
		<ptr target="https://doi.org/10.1037/ccp0000332" />
	</analytic>
	<monogr>
		<title level="j">Journal of Consulting and Clinical Psychology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="775" to="786" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood</title>
		<author>
			<persName><forename type="first">L</forename><surname>Degenhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Romaniuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Swift</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Carlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Patton</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1360-0443.2012.04015.x</idno>
		<ptr target="https://doi.org/10.1111/j.1360-0443.2012.04015.x" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="124" to="133" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Bias in meta-analysis detected by a simple, graphical test</title>
		<author>
			<persName><forename type="first">M</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Davey Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Minder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="issue">7109</biblScope>
			<biblScope unit="page" from="629" to="634" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cannabis use and psychosocial adjustment in adolescence and young adulthood</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Fergusson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Horwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Swain-Campbell</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1360-0443.2002.00103.x</idno>
		<ptr target="https://doi.org/10.1046/j.1360-0443.2002.00103.x" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1123" to="1135" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update</title>
		<author>
			<persName><forename type="first">B</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jutras-Aswad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Medina-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Pacula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Room</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Brink</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugpo.2021.103381</idno>
		<ptr target="https://doi.org/10.1016/j.drugpo.2021.103381" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Drug Policy</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page">103381</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Identifying brief intervention factors to improve cannabis related outcomes in adolescents and young adults: A systematic review of sample characteristics and intervention components</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Gex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aungst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Branson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Tomko</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.josat.2024.209335</idno>
		<ptr target="https://doi.org/10.1016/j.josat.2024.209335" />
	</analytic>
	<monogr>
		<title level="j">Journal of Substance Use and Addiction Treatment</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<date type="published" when="2024">2024. 209335</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Electronic screening and brief intervention to reduce cannabis use and consequences among graduate students presenting to a student health center: A pilot study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Goodness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Palfai</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.addbeh.2020.106362</idno>
		<ptr target="https://doi.org/10.1016/j.addbeh.2020.106362" />
	</analytic>
	<monogr>
		<title level="j">Addictive Behaviors</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page">106362</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Immediate versus delayed computerized brief intervention for illicit drug misuse</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gryczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>O'grady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ondersma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Schwartz</surname></persName>
		</author>
		<idno type="DOI">10.1097/ADM.0000000000000248</idno>
		<ptr target="https://doi.org/10.1097/ADM.0000000000000248" />
	</analytic>
	<monogr>
		<title level="j">Journal of Addiction Medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">344</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Adverse health effects of non-medical cannabis use</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Degenhardt</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(09)61037-0</idno>
		<ptr target="https://doi.org/10.1016/S0140-6736(09)61037-0" />
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="issue">9698</biblScope>
			<biblScope unit="page" from="1383" to="1391" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Brief interventions for cannabis use in emerging adults: A systematic review, metaanalysis, and evidence map</title>
		<author>
			<persName><forename type="first">J</forename><surname>Halladay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mackillop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Woock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Petker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Linton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Munn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2019.107565</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2019.107565" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page">107565</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Emergency department screening and interventions for substance use disorders</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hawk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Onofrio</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13722-018-0117-1</idno>
		<ptr target="https://doi.org/10.1186/s13722-018-0117-1" />
	</analytic>
	<monogr>
		<title level="j">Addiction Science &amp; Clinical Practice</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Distribution theory for Glass&apos;s estimator of effect size and related estimators</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Hedges</surname></persName>
		</author>
		<idno type="DOI">10.3102/10769986006002107</idno>
		<ptr target="https://doi.org/10.3102/10769986006002107" />
	</analytic>
	<monogr>
		<title level="j">Journal of Educational Statistics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="107" to="128" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P T</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gøtzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jüni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Savović</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Weeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sterne</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.d5928</idno>
		<ptr target="https://doi.org/10.1136/bmj.d5928" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="page" from="343" to="5928" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries</title>
		<author>
			<persName><forename type="first">R</forename><surname>Humeniuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Babor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L O</forename><surname>Souza-Formigoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>De Lacerda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mcree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Newcombe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Poznyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vendetti</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1360-0443.2011.03740.x</idno>
		<ptr target="https://doi.org/10.1111/j.1360-0443.2011.03740.x" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="957" to="966" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Brief interventions for cannabis use in healthcare settings: Systematic review and meta-analyses of randomized trials</title>
		<author>
			<persName><forename type="first">S</forename><surname>Imtiaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roerecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kurdyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Samokhvalov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S M</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehm</surname></persName>
		</author>
		<idno type="DOI">10.1097/ADM.0000000000000527</idno>
		<ptr target="https://doi.org/10.1097/ADM.0000000000000527" />
	</analytic>
	<monogr>
		<title level="j">Journal of Addiction Medicine</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">78</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effectiveness of brief alcohol interventions in primary care populations</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Kaner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muirhead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Pienaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bertholet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Daeppen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Burnand</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd004148.pub4</idno>
		<ptr target="https://doi.org/10.1002/14651858.cd004148.pub4" />
	</analytic>
	<monogr>
		<title level="j">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2018">2018. 2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Drug and Alcohol Dependence</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Kerridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Mauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Saha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Hasin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2017.09.032</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2017.09.032" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="223" to="228" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Medical consequences of cannabis use</title>
		<author>
			<persName><forename type="first">J</forename><surname>Khalsa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baler</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-319-90365-1_15</idno>
		<ptr target="https://doi.org/10.1007/978-3-319-90365-1_15" />
	</analytic>
	<monogr>
		<title level="m">Cannabis Use Disorders</title>
		<editor>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Montoya</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">R B</forename><surname>Weiss</surname></persName>
		</editor>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page" from="157" to="167" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Improved tests for a random effects meta-regression with a single covariate</title>
		<author>
			<persName><forename type="first">G</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hartung</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.1482</idno>
		<ptr target="https://doi.org/10.1002/sim.1482" />
	</analytic>
	<monogr>
		<title level="j">Statistics in Medicine</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2693" to="2710" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effect of computer-based substance use screening and brief behavioral counseling vs usual care for youths in pediatric primary care: A pilot randomized clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sherritt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Levinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Grubb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Samuels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vernacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wornham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Harris</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2019.6258</idno>
		<ptr target="https://doi.org/10.1001/jamanetworkopen.2019.6258" />
	</analytic>
	<monogr>
		<title level="j">JAMA Network Open</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<date type="published" when="2019">2019. 196258</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Impact of brief interventions and brief treatment on admissions to chemical dependency treatment</title>
		<author>
			<persName><forename type="first">A</forename><surname>Krupski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sears</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Joesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Estee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roy-Byrne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ries</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2010.02.018</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2010.02.018" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="126" to="136" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Cannabis and young users-a brief intervention to reduce their consumption (CANABIC): A cluster randomized controlled trial in primary care</title>
		<author>
			<persName><forename type="first">C</forename><surname>Laporte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vaillant-Roussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Blanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Eschalier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kinouani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brousse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P.-M</forename><surname>Llorca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vorilhon</surname></persName>
		</author>
		<idno type="DOI">10.1370/afm.2003</idno>
		<ptr target="https://doi.org/10.1370/afm.2003" />
	</analytic>
	<monogr>
		<title level="j">The Annals of Family Medicine</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="131" to="139" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Leadbeater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Ames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Linden-Carmichael</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.14459</idno>
		<ptr target="https://doi.org/10.1111/add.14459" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="278" to="293" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Lovell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Akhurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Padgett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Garry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Matthews</surname></persName>
		</author>
		<idno type="DOI">10.1037/pha0000326</idno>
		<ptr target="https://doi.org/10.1037/pha0000326" />
	</analytic>
	<monogr>
		<title level="j">Experimental and Clinical Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="471" to="494" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Peer network counseling with urban adolescents: A randomized controlled trial with moderate substance users</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Light</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Keyser-Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Crewe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Way</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Zaharakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mchenry</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsat.2015.06.013</idno>
		<ptr target="https://doi.org/10.1016/j.jsat.2015.06.013" />
	</analytic>
	<monogr>
		<title level="j">Journal of Substance Abuse Treatment</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="16" to="24" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Brief intervention in substance use disorders</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Mattoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ghosh</surname></persName>
		</author>
		<idno type="DOI">10.4103/0019-5545.224352</idno>
		<ptr target="https://doi.org/10.4103/0019-5545.224352" />
	</analytic>
	<monogr>
		<title level="j">Indian Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">Suppl 4</biblScope>
			<biblScope unit="page" from="466" to="S472" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Short-term efficacy of a brief intervention to reduce drug misuse and increase drug treatment utilization among adult emergency department patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Merchant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Baird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1111/acem.12767</idno>
		<ptr target="https://doi.org/10.1111/acem.12767" />
	</analytic>
	<monogr>
		<title level="j">Academic Emergency Medicine</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1172" to="1180" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Effectiveness of nurse-practitioner-delivered brief motivational intervention for young adult alcohol and drug use in primary care in South Africa: A randomized clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mertens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Bresick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Broder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Weisner</surname></persName>
		</author>
		<idno type="DOI">10.1093/alcalc/agu030</idno>
		<ptr target="https://doi.org/10.1093/alcalc/agu030" />
	</analytic>
	<monogr>
		<title level="j">Alcohol and Alcoholism</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="430" to="438" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">What works in prevention: Principles of effective prevention programs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nation</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Crusto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wandersman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Kumpfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seybolt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Morrissey-Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Davino</surname></persName>
		</author>
		<idno type="DOI">10.1037/0003-066X.58.6-7.449</idno>
		<ptr target="https://doi.org/10.1037/0003-066X.58.6-7.449" />
	</analytic>
	<monogr>
		<title level="j">American Psychologist</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">6-7</biblScope>
			<biblScope unit="page" from="449" to="456" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mckenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bossuyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Boutron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Mulrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shamseer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Tetzlaff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Akl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Glanville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grimshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hróbjartsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Lalu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Loder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mayo-Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Mcguinness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Tricco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Welch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Whiting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.n71</idno>
		<ptr target="https://doi.org/10.1136/bmj.n71" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="page" from="372" to="371" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Quarterly trends in past-month cannabis use in the United States</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Palamar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2020.108494</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2020.108494" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">219</biblScope>
			<biblScope unit="page">108494</biblScope>
			<date type="published" when="2015">2021. 2015-2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Web-based screening and brief intervention for student marijuana use in a university health center: Pilot study to examine the implementation of eCHECKUP TO GO in different contexts</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Palfai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Saitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kypri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Goodness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.addbeh.2014.04.025</idno>
		<ptr target="https://doi.org/10.1016/j.addbeh.2014.04.025" />
	</analytic>
	<monogr>
		<title level="j">Addictive Behaviors</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1346" to="1352" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Brief interventions for cannabis use disorders: A review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Parmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sarkar</surname></persName>
		</author>
		<idno type="DOI">10.1097/ADT.0000000000000100</idno>
		<ptr target="https://doi.org/10.1097/ADT.0000000000000100" />
	</analytic>
	<monogr>
		<title level="j">Addictive Disorders &amp; Their Treatment</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Screening for alcohol and drug use disorders among adults in primary care: A review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Pilowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L.-T</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.2147/SAR.S30057</idno>
		<ptr target="https://doi.org/10.2147/SAR.S30057" />
	</analytic>
	<monogr>
		<title level="j">Substance Abuse and Rehabilitation</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="25" to="34" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">A randomized controlled trial of a brief intervention for alcohol and drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary health care in Chile</title>
		<author>
			<persName><forename type="first">F</forename><surname>Poblete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Barticevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Zuzulich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Portilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Castillo-Carniglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Sapag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Villarroel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Sena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Galarce</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.13808</idno>
		<ptr target="https://doi.org/10.1111/add.13808" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1462" to="1469" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Brief interventions: Good in theory but weak in practice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Freeman</surname></persName>
		</author>
		<idno type="DOI">10.1080/09595230410001645510</idno>
		<ptr target="https://doi.org/10.1080/09595230410001645510" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Review</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="18" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Rothstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Sutton</surname></persName>
		</author>
		<title level="m">Publication bias in metaanalysis: Prevention, assessment and adjustments</title>
		<editor>
			<persName><forename type="first">M</forename><surname>Borenstein</surname></persName>
		</editor>
		<imprint>
			<publisher>John Wiley &amp; Sons</publisher>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Efficacy of brief intervention for unhealthy drug use in outpatient medical care: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sahker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Toyomoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Furukawa</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-022-07543-z</idno>
		<ptr target="https://doi.org/10.1007/s11606-022-07543-z" />
	</analytic>
	<monogr>
		<title level="j">Journal of General Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2041" to="2049" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Screening and brief intervention for unhealthy drug use: Little or no efficacy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Saitz</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpsyt.2014.00121</idno>
		<ptr target="https://www.frontiersin.org/articles/10.3389/fpsyt.2014.00121" />
	</analytic>
	<monogr>
		<title level="j">Frontiers in Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Screening and brief intervention for drug use in primary care: The ASPIRE randomized clinical trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Saitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Palfai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Alford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lloyd-Travaglini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Meli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Chaisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Samet</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2014.7862</idno>
		<ptr target="https://doi.org/10.1001/jama.2014.7862" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="502" to="513" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Investigating for whom brief substance use interventions are most effective: An individual participant data meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Schweer-Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Parr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Saitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Tanner-Smith</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11121-023-01525-1</idno>
		<ptr target="https://doi.org/10.1007/s11121-023-01525-1" />
	</analytic>
	<monogr>
		<title level="j">Prevention Science</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1459" to="1482" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Young adult sequelae of adolescent cannabis use: An integrative analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Silins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Horwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Patton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Fergusson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hutchinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Spry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Toumbourou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Degenhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Swift</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Tait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Letcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Copeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mattick</surname></persName>
		</author>
		<idno type="DOI">10.1016/S2215-0366(14)70307-4</idno>
		<ptr target="https://doi.org/10.1016/S2215-0366(14)70307-4" />
	</analytic>
	<monogr>
		<title level="j">The Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="286" to="293" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<idno>PEP23-07-03-001</idno>
		<ptr target="https://www.samhsa.gov/data/" />
	</analytic>
	<monogr>
		<title level="m">Drug Abuse Warning Network (DAWN): Findings from drug-related emergency department visits</title>
		<title level="s">Substance Abuse and Mental Health Services Administration</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Center for Behavioral Health Statistics and Quality</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health</title>
		<idno>PEP23-07-01-006</idno>
		<ptr target="https://www.samhsa.gov/data/" />
	</analytic>
	<monogr>
		<title level="m">Center for Behavioral Health Statistics and Quality</title>
		<title level="s">Substance Abuse and Mental Health Services Administration</title>
		<imprint>
			<date type="published" when="2023">2023b</date>
		</imprint>
	</monogr>
	<note>NSDUH Series H-58</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Effectiveness of a brief-intervention and continuity of care in enhancing attendance for treatment by adolescent substance users</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Tait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Hulse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Robertson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2004.01.003</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2004.01.003" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="289" to="296" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Effects of brief substance use interventions delivered in general medical settings: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Tanner-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Parr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schweer-Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Saitz</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.15674</idno>
		<ptr target="https://doi.org/10.1111/add.15674" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="877" to="889" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Conducting meta-analyses in R with the metafor package</title>
		<author>
			<persName><forename type="first">W</forename><surname>Viechtbauer</surname></persName>
		</author>
		<idno type="DOI">10.18637/jss.v036.i03</idno>
		<ptr target="https://doi.org/10.18637/jss.v036.i03" />
	</analytic>
	<monogr>
		<title level="j">Journal of Statistical Software</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1" to="48" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">A randomized clinical trial examining the effect of videobased prevention of alcohol and marijuana use among recent sexual assault victims</title>
		<author>
			<persName><forename type="first">K</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Gilmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Frazier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ledray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Acierno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Ruggiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Resnick</surname></persName>
		</author>
		<idno type="DOI">10.1111/acer.13505</idno>
		<ptr target="https://doi.org/10.1111/acer.13505" />
	</analytic>
	<monogr>
		<title level="j">Alcoholism: Clinical and Experimental Research</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2163" to="2172" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Walton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bohnert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Resko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Chermack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Zucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zimmerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Blow</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2013.04.020</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2013.04.020" />
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="646" to="653" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">A randomized controlled trial testing the efficacy of a brief cannabis universal prevention program among adolescents in primary care</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Walton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Resko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Chermack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Zucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zimmerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Blow</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.12469</idno>
		<ptr target="https://doi.org/10.1111/add.12469" />
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="786" to="797" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<idno type="DOI">10.1046/j.1360-0443.2002.00185.x</idno>
		<ptr target="https://doi.org/10.1046/j.1360-0443.2002.00185.x" />
	</analytic>
	<monogr>
		<title level="m">The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility</title>
		<imprint>
			<publisher>WHO ASSIST Working Group</publisher>
			<date type="published" when="2002">2002</date>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1183" to="1194" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Project Reduce: Reducing alcohol and marijuana misuse: effects of a brief intervention in the emergency department</title>
		<author>
			<persName><forename type="first">R</forename><surname>Woolard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Longabaugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nirenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Becker</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.addbeh.2012.09.006</idno>
		<ptr target="https://doi.org/10.1016/j.addbeh.2012.09.006" />
	</analytic>
	<monogr>
		<title level="j">Addictive Behaviors</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1732" to="1739" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title level="m" type="main">Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. Drug and Alcohol Dependence</title>
		<author>
			<persName><forename type="first">L.-T</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mannelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Swartz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2017.03.037</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2017.03.037" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="153" to="162" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
